Enanta Pharmaceuticals
Discovering small molecule drugs
- B2B
About Enanta Pharmaceuticals
Specializing in drug discovery for virology and immunology, with a focus on RSV and CSU, Enanta develops small molecule drugs like glecaprevir for various infections
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- watertown, massachusetts, United States
- Founded
- 1995
- Revenue
- $65.3MFY2025, publicly reported
- Website
- enanta.com
Enanta Pharmaceuticals at a glance
Enanta Pharmaceuticals is a B2B company in the Biotechnology Research industry, headquartered in watertown, massachusetts, United States.
Enanta Pharmaceuticals was founded in 1995.
Enanta Pharmaceuticals has 51–250 employees.
Enanta Pharmaceuticals's revenue is $65.3M (FY2025, publicly reported).
Frequently asked questions about Enanta Pharmaceuticals
What is Enanta Pharmaceuticals's revenue?
Enanta Pharmaceuticals's revenue is $65.3M (FY2025, publicly reported).
How many employees does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals has 51–250 employees.
Where is Enanta Pharmaceuticals headquartered?
Enanta Pharmaceuticals is headquartered in watertown, massachusetts, United States.
Selling to companies like Enanta Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies